Posts

Showing posts from May, 2014

Qiagen Acquires Biobase Assets

Qiagen has purchased the assets of Biobase, a Wolfenbüttel, Germany-based provider of curated biological databases, for an undisclosed sum. Qiagen said that Biobase will be renamed Qiagen Wolfenbüttel. Also, Michael Tysiak, BioBase's CEO, will join Qiagen as general manager of the newly purchased company. Founded in 2007, Biobase provides access to curated data assembled by subject matter experts and organized in an accessible and easy to search manner. Its databases support projects focused on functional and gene regulation analyses, variant annotation, pharmacogenetics-based analysis, and more. Among its repositories are the Human Gene Mutation Database (HGMD), which offers access to information on inherited disease mutations; GenomeTrac, which contains data on pathogenic variants; the PharmacoGenomic Mutation Database, which serves as a resource for locating variants that affect drug response; and the Transcription Factor Binding Sites database, which contains information o